S-1 Clinical Trials
16 recruitingDrug
Phase 215Phase 13Phase 32
Showing 1–16 of 16 trials
Recruiting
Phase 2
Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer
Gastric Cancer
Fudan University30 enrolled1 locationNCT07194005
Recruiting
Phase 2
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial
Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen208 enrolled6 locationsNCT07070479
Recruiting
Phase 1Phase 2
A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer
Gastric (Stomach) CancerStomach Neoplasm
Asan Medical Center57 enrolled2 locationsNCT06732856
Recruiting
Phase 1Phase 2
IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer
Gastric Cancer
Ruijin Hospital55 enrolled1 locationNCT07025889
Recruiting
Phase 2
ONO-4538 Phase II Rollover Study (ONO-4538-98)
Pan-tumor
Ono Pharmaceutical Co. Ltd59 enrolled38 locationsNCT04566380
Recruiting
Phase 2
Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC
FruquintinibS-1Raltitrexed
Meng Qiu66 enrolled2 locationsNCT06427005
Recruiting
Phase 2
Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC
Recurrent or Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University56 enrolled1 locationNCT06657690
Recruiting
Phase 2
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
Metastatic Gastric CancerUnresectable Gastric CarcinomaHER2-positive Gastric Cancer
Qilu Hospital of Shandong University110 enrolled20 locationsNCT06730373
Recruiting
Phase 2
A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancer
Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University40 enrolled1 locationNCT06555471
Recruiting
Phase 2
Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer
Gastric CancerStomach NeoplasmsLinitis Plastica of Stomach
Sun Yat-sen University53 enrolled1 locationNCT06451211
Recruiting
Phase 2Phase 3
Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer
Immunotherapy Gastrict Cancer
Fujian Cancer Hospital130 enrolled1 locationNCT05699655
Recruiting
Phase 2
Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM
Gastric CancerGastric Cancer Metastatic to Regional Lymph Nodes
The First Affiliated Hospital with Nanjing Medical University40 enrolled1 locationNCT06341595
Recruiting
Phase 2
Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007)
Locally Advanced Esophageal Squamous Cell Carcinoma
Sun Yat-sen University140 enrolled1 locationNCT06187597
Recruiting
Phase 3
A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
Esophageal Squamous Cell Carcinoma
Beijing Konruns Pharmaceutical Co., Ltd.490 enrolled1 locationNCT06194734
Recruiting
Phase 1Phase 2
RC48-ADC Combined With S-1 for First-line Treatment of Advanced Gastroesophageal Adenocarcinoma With Moderate Expression of HER2
Advanced Gastroesophageal Adenocarcinoma
Chinese PLA General Hospital42 enrolled3 locationsNCT05403242
Recruiting
Phase 2
Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma
Gastric CancerGastroesophageal-junction Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School140 enrolled3 locationsNCT05687357